NeuPath Health Inc.
NPTH.V
TSX
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -153.52% | -612.70% | 44.94% | 97.59% | 91.72% |
| Total Depreciation and Amortization | -12.31% | -13.05% | 4.80% | 6.10% | 6.41% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 1,347.19% | 4,287.77% | -24.60% | -91.54% | -95.96% |
| Change in Net Operating Assets | 46.68% | -107.12% | -57.49% | -107.92% | 517.06% |
| Cash from Operations | 21.43% | -15.44% | -6.25% | -4.08% | 236.33% |
| Capital Expenditure | -242.16% | -164.14% | -141.10% | -45.17% | 72.20% |
| Sale of Property, Plant, and Equipment | -99.21% | -99.21% | -100.00% | -- | -- |
| Cash Acquisitions | 100.00% | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -159.28% | -168.01% | -159.31% | 318.60% | 218.33% |
| Total Debt Issued | 597.42% | -100.00% | -97.50% | -100.00% | 676.67% |
| Total Debt Repaid | -97.67% | 56.56% | 56.14% | 11.23% | -3.46% |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -56.72% | -51.39% | -35.86% | -38.61% | -5.18% |
| Cash from Financing | 59.54% | 41.64% | 46.13% | -28.95% | 21.26% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -7.18% | -115.19% | -93.02% | 199.59% | 151.04% |